Platform & Pipeline

Restoring balance to the immune system has huge potential in the fight against autoimmune disease. These are our initial areas of focus.

Dscf4395 Aspect Ratio 354 421
Dscf4446 Aspect Ratio 317 300

Our Platform

Our platform is built on decades of research by our founders, who are pioneers in Treg biology and cell therapy.

Dscf4543 Aspect Ratio 1558 1333

Our Pipeline

We are applying our approach to combat specific disease states.

Dscf4462 Crop Aspect Ratio 1569 1429
Science Barker2 Aspect Ratio 611 614

Our Science

We are developing therapies designed to impact both sides of the immune imbalance, with Treg cell therapeutics and a Teff modulating biologic.